$NEO
NEOGENOMICS INC

2013 Q4 Form 10-K Financial Statement

#000119312514064714 Filed on February 24, 2014

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2013 Q2
Revenue $18.32M $16.88M $15.60M
YoY Change 23.02% 18.88% -0.05%
Cost Of Revenue $9.200M $8.713M $8.446M
YoY Change 8.24% 4.85% 3.0%
Gross Profit $9.163M $8.171M $7.157M
YoY Change 42.44% 38.68% -2.85%
Gross Profit Margin 50.01% 48.39% 45.87%
Selling, General & Admin $7.300M $6.671M $6.036M
YoY Change 25.86% 15.66% 0.6%
% of Gross Profit 79.67% 81.64% 84.34%
Research & Development $600.0K $340.0K $616.0K
YoY Change 50.0% -57.92% 23.2%
% of Gross Profit 6.55% 4.16% 8.61%
Depreciation & Amortization $1.120M $1.130M $1.110M
YoY Change -1.75% 13.0% 20.65%
% of Gross Profit 12.22% 13.83% 15.51%
Operating Expenses $7.900M $7.011M $6.652M
YoY Change 27.42% 6.61% 0.79%
Operating Profit $1.263M $1.160M $505.0K
YoY Change 442.06% -269.59% -34.16%
Interest Expense -$200.0K $231.0K -$200.0K
YoY Change -33.33% -20.62% -33.33%
% of Operating Profit -15.84% 19.91% -39.6%
Other Income/Expense, Net -$231.0K
YoY Change
Pretax Income $1.000M $929.0K $273.0K
YoY Change -1100.0% -195.28% -54.5%
Income Tax $100.0K $29.00K $0.00
% Of Pretax Income 10.0% 3.12% 0.0%
Net Earnings $857.0K $900.0K $273.0K
YoY Change -851.75% -192.31% -50.45%
Net Earnings / Revenue 4.68% 5.33% 1.75%
Basic Earnings Per Share $0.02 $0.02 $0.01
Diluted Earnings Per Share $0.02 $0.02 $0.01
COMMON SHARES
Basic Shares Outstanding 49.02M shares 48.93M shares 48.79M shares
Diluted Shares Outstanding 53.64M shares 53.17M shares 53.74M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.800M $4.900M $4.600M
YoY Change 152.63% 145.0% 76.92%
Cash & Equivalents $4.834M $4.929M $4.636M
Short-Term Investments
Other Short-Term Assets $1.700M $1.100M $800.0K
YoY Change 112.5% -8.33% -27.27%
Inventory $2.301M $2.068M $1.700M
Prepaid Expenses $1.115M
Receivables $18.65M $15.73M $16.00M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $27.49M $23.83M $23.20M
YoY Change 47.95% 39.34% 39.76%
LONG-TERM ASSETS
Property, Plant & Equipment $9.694M $8.592M $8.400M
YoY Change 12.63% -6.61% 0.0%
Goodwill
YoY Change
Intangibles $2.577M $2.633M
YoY Change -7.96%
Long-Term Investments
YoY Change
Other Assets $154.0K $178.0K $200.0K
YoY Change 85.54% 78.0% 100.0%
Total Long-Term Assets $12.43M $11.40M $11.30M
YoY Change 8.14% -6.53% -0.88%
TOTAL ASSETS
Total Short-Term Assets $27.49M $23.83M $23.20M
Total Long-Term Assets $12.43M $11.40M $11.30M
Total Assets $39.92M $35.23M $34.50M
YoY Change 32.74% 20.24% 23.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.177M $3.780M $3.400M
YoY Change 15.67% 18.13% 9.68%
Accrued Expenses $741.0K $755.0K $2.900M
YoY Change 10.76% -73.97% -3.33%
Deferred Revenue
YoY Change
Short-Term Debt $4.300M $2.700M $3.200M
YoY Change -49.41% -66.25% -50.0%
Long-Term Debt Due $2.800M $2.600M $2.600M
YoY Change 27.27% 4.0% 0.0%
Total Short-Term Liabilities $14.32M $12.25M $12.10M
YoY Change -19.34% -26.67% -19.87%
LONG-TERM LIABILITIES
Long-Term Debt $3.300M $2.700M $3.000M
YoY Change 6.45% -20.59% -6.25%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.882M $2.700M $3.000M
YoY Change 25.35% -20.59% -6.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.32M $12.25M $12.10M
Total Long-Term Liabilities $3.882M $2.700M $3.000M
Total Liabilities $18.21M $14.90M $15.00M
YoY Change -12.71% -25.86% -18.03%
SHAREHOLDERS EQUITY
Retained Earnings -$20.54M -$21.40M
YoY Change -9.01%
Common Stock $42.25M $41.72M
YoY Change 32.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $21.71M $20.33M $19.40M
YoY Change
Total Liabilities & Shareholders Equity $39.92M $35.23M $34.50M
YoY Change 32.74% 20.24% 23.21%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2013 Q2
OPERATING ACTIVITIES
Net Income $857.0K $900.0K $273.0K
YoY Change -851.75% -192.31% -50.45%
Depreciation, Depletion And Amortization $1.120M $1.130M $1.110M
YoY Change -1.75% 13.0% 20.65%
Cash From Operating Activities -$500.0K $2.200M $1.860M
YoY Change -531.37% 70.64%
INVESTING ACTIVITIES
Capital Expenditures -$520.0K -$880.0K -$370.0K
YoY Change 48.57% -29.6% -50.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$520.0K -$880.0K -$370.0K
YoY Change 48.57% -29.6% -50.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 930.0K -1.020M -1.490M
YoY Change 416.67% -182.93% 175.93%
NET CHANGE
Cash From Operating Activities -500.0K 2.200M 1.860M
Cash From Investing Activities -520.0K -880.0K -370.0K
Cash From Financing Activities 930.0K -1.020M -1.490M
Net Change In Cash -90.00K 300.0K 0.000
YoY Change -47.06% -156.6% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$500.0K $2.200M $1.860M
Capital Expenditures -$520.0K -$880.0K -$370.0K
Free Cash Flow $20.00K $3.080M $2.230M
YoY Change -94.29% 316.22% 21.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49120476 shares
CY2007Q2 ngnm Warrants Issued
WarrantsIssued
348417 shares
CY2013Q1 us-gaap Share Price
SharePrice
3.00
CY2013Q2 dei Entity Public Float
EntityPublicFloat
166600000
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.87
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5470544 shares
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
3135000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1097000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
90000 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.87
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
5897000
CY2011Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4779670 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.51
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.44
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2628000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45280280 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45280280 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
40000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.02
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5777712 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.71
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.73
CY2012Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1702378 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.44
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
669000
CY2012Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2212000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10289000
CY2012Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
8458000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3611000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17758000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2808000
CY2012Q4 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
3910000
CY2012Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
3097000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
9216000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
31742000
CY2012Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3002000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22571000
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
182000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
45000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30071000
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
CY2012Q4 us-gaap Liabilities
Liabilities
20855000
CY2012Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3097000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Capital Leases Balance Sheet Assets By Major Class Net
CapitalLeasesBalanceSheetAssetsByMajorClassNet
4163000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
18581000
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2800000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
83000
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
820000
CY2012Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
8073000
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
CY2012Q4 us-gaap Assets
Assets
30071000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1868000
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18896000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14034000
CY2012Q4 us-gaap Inventory Net
InventoryNet
1859000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.19
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1520625 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.44
CY2013Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.24
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
741000
CY2013Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2786000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
754000
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2800000
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2982000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
820000
CY2012Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
13600000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8607000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49118373 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4205173 shares
CY2013Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
5725798 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49118373 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
8000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.22
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5725798 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
662065 shares
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.89
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
1.22
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
7000000 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1358333 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.89
CY2013Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
4205173 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.02
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14478000
CY2013Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
3162000
CY2013Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
4282000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2553000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4177000
CY2013Q4 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
420000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
334000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14323000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2337000
CY2013Q4 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
5038000
CY2013Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
3294000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
21711000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
42200000
CY2013Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4540000
CY2013Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
1181000
CY2013Q4 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
6080000
CY2013Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
5700000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20538000
CY2013Q4 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
196000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
405000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
49000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39916000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
588000
CY2013Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
1755000
CY2013Q4 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
4300000
CY2013Q4 us-gaap Liabilities
Liabilities
18205000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
526000
CY2013Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3882000
CY2013Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
6722000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
939000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1462000
CY2013Q4 us-gaap Capital Leases Balance Sheet Assets By Major Class Net
CapitalLeasesBalanceSheetAssetsByMajorClassNet
5469000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
27491000
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2577000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
154000
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1115000
CY2013Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
10507000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
223000
CY2013Q4 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
642000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
223000
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
588000
CY2013Q4 us-gaap Assets
Assets
39916000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
13800000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4834000
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18653000
CY2013Q4 us-gaap Inventory Net
InventoryNet
2301000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
223000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
24172000
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2577000
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
11500000
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2982000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1115000
CY2013Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
4600000
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
654000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
223000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
223000
CY2011 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2011 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42758000 shares
CY2013Q1 ngnm Proceeds From Issuance Of Common Stock Gross
ProceedsFromIssuanceOfCommonStockGross
10000000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0118 pure
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9694000
CY2013Q4 ngnm Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber
4205173 shares
CY2013Q4 ngnm Capital Leases Future Minimum Payments Due In Six Years
CapitalLeasesFutureMinimumPaymentsDueInSixYears
8000
CY2013Q4 ngnm Capital Leases Weighted Average Interest Rate
CapitalLeasesWeightedAverageInterestRate
0.093 pure
CY2013Q4 ngnm Maximum Milestone Payment To Be Made
MaximumMilestonePaymentToBeMade
5000000
CY2013Q4 ngnm Milestone Payment To Be Made Upon Incremental Revenue
MilestonePaymentToBeMadeUponIncrementalRevenue
500000
CY2013Q4 ngnm Property Plant And Equipment Minimum Cost
PropertyPlantAndEquipmentMinimumCost
1000
CY2013Q4 ngnm Royalty Payable As Percentage Of Net Revenue
RoyaltyPayableAsPercentageOfNetRevenue
0.065 pure
CY2013Q4 ngnm Royalty Payable As Percentage Of Sublicensing Revenue
RoyaltyPayableAsPercentageOfSublicensingRevenue
0.50 pure
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2013Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
12000000
CY2011Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
120000 shares
CY2012Q1 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2015-03-26
CY2012Q1 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.020 pure
CY2012Q1 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
80000
CY2012Q1 ngnm Line Of Credit Facility Commitment Fee Percentage If Revolver Terminated One Year Before Amendment Date
LineOfCreditFacilityCommitmentFeePercentageIfRevolverTerminatedOneYearBeforeAmendmentDate
0.025 pure
CY2012Q1 ngnm Line Of Credit Facility Commitment Fee Percentage If Revolver Terminated Two Years After Amendment Date
LineOfCreditFacilityCommitmentFeePercentageIfRevolverTerminatedTwoYearsAfterAmendmentDate
0.005 pure
CY2012Q1 ngnm Line Of Credit Facility Commitment Fee Percentage If Revolver Terminated Two Years Before Amendment Date
LineOfCreditFacilityCommitmentFeePercentageIfRevolverTerminatedTwoYearsBeforeAmendmentDate
0.015 pure
CY2012Q1 ngnm Minimum Termination Fee Grace Period
MinimumTerminationFeeGracePeriod
P5D
CY2013Q4 ngnm Base Salary
BaseSalary
1635000
CY2012Q2 ngnm Related Party Retainer Compensation
RelatedPartyRetainerCompensation
210000
CY2013Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3322500 shares
CY2013Q1 us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
800000
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9200000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.55 pure
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.15
CY2011 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.39
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
69000
CY2011 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.03
CY2011 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
122401 shares
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.95
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
519000 shares
CY2011 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42758000 shares
CY2011 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
382500 shares
CY2011 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.03
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
827374 shares
CY2011 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
1579000
CY2011 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
285000
CY2011 us-gaap Gross Profit
GrossProfit
19428000
CY2011 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
55000
CY2011 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
2950000
CY2011 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
321000
CY2011 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
83000
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
367000
CY2011 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2011 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-25000
CY2011 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
90000
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-409000
CY2011 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
CY2011 us-gaap Interest Paid
InterestPaid
735000
CY2011 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
43484000
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1177000
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5226000
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-1177000
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
315000
CY2011 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
153000
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3002000
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
897000
CY2011 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
285000
CY2011 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3482000
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12331000
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2359000
CY2011 us-gaap Cost Of Services
CostOfServices
24056000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
126000
CY2011 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2567000
CY2011 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1531000
CY2011 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6963000
CY2011 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
797000
CY2011 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
1667000
CY2011 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
105000
CY2011 us-gaap Interest Expense
InterestExpense
768000
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-897000
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
543000
CY2011 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
456000
CY2011 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
40000
CY2011 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
CY2011 us-gaap Depreciation
Depreciation
2085000
CY2011 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
367000
CY2011 ngnm Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Aggregate Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAggregateGrantDateFairValue
267000
CY2011 ngnm Oncology Practice Combined Represented Revenue
OncologyPracticeCombinedRepresentedRevenue
0.113 pure
CY2011 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
CY2011 us-gaap Operating Expenses
OperatingExpenses
19837000
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2011 ngnm Transaction Fees And Expenses
TransactionFeesAndExpenses
41000
CY2011 ngnm Warrant And Restricted Stock Expense
WarrantAndRestrictedStockExpense
173000
CY2013 dei Entity Registrant Name
EntityRegistrantName
NEOGENOMICS INC
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001077183
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
shares
CY2013 us-gaap Operating Loss Carryforwards Expiration Date
OperatingLossCarryforwardsExpirationDate
2031-12-31
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
573588 shares
CY2013 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P2Y2M12D
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0070 pure
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52775000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.46 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400 pure
CY2013 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P1Y9M18D
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.47
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0.57
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0693 pure
CY2013 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.04 pure
CY2013 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
4512000 shares
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.66
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0026 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Meals And Entertainment
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
0.0189 pure
CY2013 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.50 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.44
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.4544 pure
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.63
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.20
CY2013 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P1Y
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2013 us-gaap Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage
DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
0.02 pure
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2227000
CY2013 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.04
CY2013 us-gaap Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
"The LIBOR shall be not less than 2.0%" and replacing it with "the LIBOR shall be not less than 1.0%"
CY2013 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
76595 shares
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.85
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
416000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2013 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y6M
CY2013 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
230000
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9968000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2011000
CY2013 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
666000
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48263000 shares
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
24165 shares
CY2013 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.0525 pure
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
438998 shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0177 pure
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
442000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
32000 shares
CY2013 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
5000000
CY2013 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.04
CY2013 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
2606000
CY2013 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
666000
CY2013 us-gaap Gross Profit
GrossProfit
31737000
CY2013 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
71000
CY2013 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
3249000
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
349000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
28916 shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.1445 pure
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> <u>Use of Estimates</u></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America. These principles require management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, together with amounts disclosed in the related notes to the consolidated financial statements. Actual results and outcomes may differ from management&#x2019;s estimates, judgments and assumptions. Significant estimates, judgments and assumptions used in these consolidated financial statements include, but are not limited to, those related to revenues, accounts receivable and related allowances, contingencies, useful lives and recovery of long-term assets, income taxes, and the fair value of stock-based compensation. These estimates, judgments, and assumptions are reviewed periodically and the effects of material revisions in estimates are reflected in the consolidated financial statements prospectively from the date of the change in estimate.</p> </div>
CY2013 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
263000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
372000
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
17000
CY2013 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
932000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
3174000
CY2013 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
CY2013 us-gaap Interest Paid
InterestPaid
1073000
CY2013 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
66467000
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
560000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2185000
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7416000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
2033000
CY2013 ngnm Area Of Office Space
AreaOfOfficeSpace
49000 sqft
CY2013 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2013 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
9533000
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17397000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2750000
CY2013 us-gaap Cost Of Services
CostOfServices
34730000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1200000
CY2013 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2797000
CY2013 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2966000
CY2013 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8726000
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
59000
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1072000
CY2013 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
868000
CY2013 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
275000
CY2013 us-gaap Interest Expense
InterestExpense
989000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2011000
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2440000
CY2013 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-4177000
CY2013 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
49000
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
223000
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
152000
CY2013 us-gaap Depreciation
Depreciation
4189000
CY2013 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
372000
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
93000
CY2013 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
CY2013 us-gaap Operating Expenses
OperatingExpenses
28563000
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
152000
CY2013 ngnm Agreement Expiration Date
AgreementExpirationDate
2017-01-05
CY2013 ngnm Initial Contract Termination Date
InitialContractTerminationDate
2014-05-14
CY2013 ngnm Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Aggregate Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAggregateGrantDateFairValue
493000
CY2013 ngnm Amount Of Revenue Recognized For Milestone
AmountOfRevenueRecognizedForMilestone
2000000
CY2013 ngnm Deemed Value Per Share Of Consideration Payable To Common Stockholders In Event Of Change In Control
DeemedValuePerShareOfConsiderationPayableToCommonStockholdersInEventOfChangeInControl
3.62
CY2013 ngnm Individual Clients Revenue
IndividualClientsRevenue
Less than 5%
CY2013 ngnm Largest Amount Of Tax Benefit
LargestAmountOfTaxBenefit
Greater than 50%
CY2013 ngnm Oncology Practice Combined Represented Revenue
OncologyPracticeCombinedRepresentedRevenue
0.158 pure
CY2013 ngnm Related Party Retainer Compensation
RelatedPartyRetainerCompensation
180000
CY2013 ngnm Share Based Compensation Arrangement Amended Plan Expiration Date
ShareBasedCompensationArrangementAmendedPlanExpirationDate
2019-03-03
CY2013 ngnm Taxable Income Net
TaxableIncomeNet
4200000
CY2013 ngnm Taxable Income Permanent Differences
TaxableIncomePermanentDifferences
3100000
CY2013 ngnm Transaction Fees And Expenses
TransactionFeesAndExpenses
1037000
CY2013 ngnm Agreed Duration To Commercialize Products
AgreedDurationToCommercializeProducts
P1Y
CY2013 ngnm Extended Duration To Commercialize Products
ExtendedDurationToCommercializeProducts
P2Y
CY2013 ngnm Warrant And Restricted Stock Expense
WarrantAndRestrictedStockExpense
263000
CY2013 ngnm Provision For Federal Regular Income Tax
ProvisionForFederalRegularIncomeTax
0
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0060 pure
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48715000 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.51 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.60
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2012 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
3688000 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.44
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.64
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-492000
CY2012 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.00
CY2012 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
56805 shares
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.02
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1298000 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45027000 shares
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
197209 shares
CY2012 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.00
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
102749 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
50000 shares
CY2012 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
2187000
CY2012 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
575000
CY2012 us-gaap Gross Profit
GrossProfit
26836000
CY2012 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-46000
CY2012 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
2782000
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
218000
CY2012 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
223000
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
198000
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2012 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-96000
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
1211000
CY2012 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1037000
CY2012 us-gaap Interest Paid
InterestPaid
1108000
CY2012 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
59867000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
65000
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9192000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
65000
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
657000
CY2012 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
89000
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2615000
CY2012 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
575000
CY2012 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
511000
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15843000
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3384000
CY2012 us-gaap Cost Of Services
CostOfServices
33031000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
264000
CY2012 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3053000
CY2012 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
1945000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-760000
CY2012 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7501000
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1123000
CY2012 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
1443000
CY2012 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
220000
CY2012 us-gaap Interest Expense
InterestExpense
1146000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3652000
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2281000
CY2012 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
4560000
CY2012 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
38000
CY2012 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
182000
CY2012 us-gaap Depreciation
Depreciation
3636000
CY2012 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
201000
CY2012 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
500000
CY2012 us-gaap Operating Expenses
OperatingExpenses
25625000
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2012 ngnm Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Aggregate Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAggregateGrantDateFairValue
943000
CY2012 ngnm Exercise Of Warrants
ExerciseOfWarrants
262000
CY2012 ngnm Albitar Warrant Period
AlbitarWarrantPeriod
P5Y
CY2012 ngnm Oncology Practice Combined Represented Revenue
OncologyPracticeCombinedRepresentedRevenue
0.149 pure
CY2012 ngnm Stock Issued During Period Value Intangibles
StockIssuedDuringPeriodValueIntangibles
1945000
CY2012 ngnm Taxable Income Net
TaxableIncomeNet
1300000
CY2012 ngnm Taxable Income Permanent Differences
TaxableIncomePermanentDifferences
1000000
CY2012 ngnm Transaction Fees And Expenses
TransactionFeesAndExpenses
38000
CY2012 ngnm Warrant And Restricted Stock Expense
WarrantAndRestrictedStockExpense
223000
CY2011Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2011Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41734000 shares
CY2011Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2011Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41734000 shares
CY2011Q1 us-gaap Gross Profit
GrossProfit
3865000
CY2011Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
8805000
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
-893000
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50923000 shares
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46624000 shares
CY2013Q1 us-gaap Gross Profit
GrossProfit
7246000
CY2013Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
15657000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
3000
CY2013Q1 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
10000
CY2011Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2011Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42857000 shares
CY2011Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2011Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42857000 shares
CY2011Q2 us-gaap Gross Profit
GrossProfit
4656000
CY2011Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
10466000
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
-293000
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47424000 shares
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44697000 shares
CY2012Q1 us-gaap Gross Profit
GrossProfit
7144000
CY2012Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
15160000
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
603000
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47650000 shares
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44954000 shares
CY2012Q2 us-gaap Gross Profit
GrossProfit
7367000
CY2012Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
15611000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
551000
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53744000 shares
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
273000
CY2011Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48793000 shares
CY2013Q2 us-gaap Gross Profit
GrossProfit
7157000
CY2013Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
15603000
CY2011Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45270000 shares
CY2011Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2011Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43104000 shares
CY2011Q4 us-gaap Gross Profit
GrossProfit
5833000
CY2011Q4 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
12893000
CY2011Q4 us-gaap Net Income Loss
NetIncomeLoss
152000
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2012Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45273000 shares
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2012Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45273000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53173000 shares
CY2012Q4 us-gaap Gross Profit
GrossProfit
6433000
CY2012Q4 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
14894000
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-114000
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48933000 shares
CY2013Q3 us-gaap Gross Profit
GrossProfit
8171000
CY2013Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
16884000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
900000
CY2013Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53638000 shares
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2013Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49021000 shares
CY2013Q4 us-gaap Gross Profit
GrossProfit
9163000
CY2013Q4 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
18323000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
857000
CY2011Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2011Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43104000 shares
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2011Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43104000 shares
CY2011Q3 us-gaap Gross Profit
GrossProfit
5074000
CY2011Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
11320000
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
-143000
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45175000 shares
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45175000 shares
CY2012Q3 us-gaap Gross Profit
GrossProfit
5892000
CY2012Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
14202000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-975000
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02

Files In Submission

Name View Source Status
0001193125-14-064714-index-headers.html Edgar Link pending
0001193125-14-064714-index.html Edgar Link pending
0001193125-14-064714.txt Edgar Link pending
0001193125-14-064714-xbrl.zip Edgar Link pending
d647097d10k.htm Edgar Link pending
d647097dex1060.htm Edgar Link pending
d647097dex211.htm Edgar Link pending
d647097dex231.htm Edgar Link pending
d647097dex311.htm Edgar Link pending
d647097dex312.htm Edgar Link pending
d647097dex313.htm Edgar Link pending
d647097dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g647097img10.jpg Edgar Link pending
g647097img11.jpg Edgar Link pending
g647097img40.jpg Edgar Link pending
g647097img44.jpg Edgar Link pending
g647097img46.jpg Edgar Link pending
g647097img47.jpg Edgar Link pending
g647097img8.jpg Edgar Link pending
ngnm-20131231.xml Edgar Link completed
ngnm-20131231.xsd Edgar Link pending
ngnm-20131231_cal.xml Edgar Link unprocessable
ngnm-20131231_def.xml Edgar Link unprocessable
ngnm-20131231_lab.xml Edgar Link unprocessable
ngnm-20131231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending